Dr. Steven T. Bailey, MD
Retina Specialist (Retina Specialist (Ophthalmology) Physician)
- Medicare participating
At a glance
- Medical school
- University of Iowa, Rj & L Carver College of Medicine (2002)
- Years since graduation
- 24
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 556
Licensed in Washington since 2008, according to the Washington State Department of Health. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2002Medical school: University of Iowa, Rj & L Carver College of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Retina Specialist (Ophthalmology) Physician primary
OR license MD26783 · WA license MD60005640 (first issued 2008; active) -
Ophthalmology Physician
OR license MD26783 · WA license MD60005640 (first issued 2008; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Ohsu Hospital and Clinics Portland, OR
Medical groups
- University Professional Services (1,724 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 556
- Services billed
- 18,336
- Patients’ average age
- 76
| Service | Times | Patients |
|---|---|---|
| Imaging of retina | 1,804 | 575 |
| Injection of drug into eye | 1,194 | 247 |
| Established patient office or other outpatient visit, 30-39 minutes | 1,097 | 531 |
| Injection, aflibercept, 1 mg | 962 | 71 |
| Compounded drug, not otherwise classified | 466 | 90 |
| Injection, ranibizumab, 0.1 mg | 393 | 11 |
| Established patient office or other outpatient visit, 20-29 minutes | 86 | 60 |
| New patient office or other outpatient visit, 45-59 minutes | 39 | 39 |
| Exam of retinal blood vessels using a special camera after injection of a dye | 11 | 11 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Prednisolone Acetate Other prescribers in Portland, OR | 30 |
| Brimonidine Tartrate Other prescribers in Portland, OR | 23 |
| Dorzolamide-Timolol (dorzolamide hcl/timolol maleat) Other prescribers in Portland, OR | 20 |
| Timolol Maleate Other prescribers in Portland, OR | 18 |
| Latanoprost Other prescribers in Portland, OR | 16 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $27,087 in research payments for these studies, mostly to the institutions running them.
- IAMD Observational Study
Genentech, Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.